A cutting of Philodendron gloriosum — velvet-leafed, heart-shaped, with creamy venation — costs, at the time of writing, between eighty and four hundred US dollars on the secondary market. Ten years ago, it cost fifteen dollars, if you could find one.
The gap between those numbers is where most of the ethical complications of rare plant collecting live.
Where the plants come from
Most aroids in the rare trade are now tissue-cultured in commercial greenhouses in the Netherlands, Indonesia, or Florida. A tissue-cultured plant is, by any reasonable measure, ethically neutral: it is grown in a sterile lab from a few cells of a parent plant, no wild population disturbed.
But not all of them. A meaningful minority — nobody has good numbers — are still wild-collected from Central and South American rainforests, shipped via grey channels, and resold to collectors who do not always ask.
What to ask
If you are paying more than forty dollars for a cutting, ask three questions:
1. Is this tissue-cultured or cutting-propagated? Both are fine. "Wild-collected" is the answer you do not want. 2. Who was the parent plant? A good seller will tell you. A suspicious seller will deflect. 3. How long has it been in cultivation? Plants that have been lab-propagated for generations are the safest.
None of this is a moral test. It is a practical one. The rare trade exists. The question is whether you want to support the parts of it that are transparent.
